BamSEC and AlphaSense Join Forces
Learn More

Kura Oncology Inc.

NASDAQ: KURA    
Share price (1/6/25): $8.51    
Market cap (1/6/25): $662 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 4 pages Kura Oncology, Inc. Second Amendment to Amended and Restated Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 50 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 10-Q 40 pages Kura Oncology, Inc. $150,000,000 Common Stock Sales Agreement
12/34/56
EX-10.2
from 10-Q 11 pages This First Amendment to Lease (This “Amendment”), Is Made as of the 30th Day of August, 2023, by and Between East Office Operating Limited Partnership, a Massachusetts Limited Partnership, With an Address C/O Pembroke Real Estate LLC, 255 State Street, Boston, Massachusetts 02109 (The “Landlord”) and Kura Oncology, Inc, a Delaware Corporation, With an Address of 12730 High Bluff Drive, Suite 400, San Diego, California 92130 (The “Tenant”)
12/34/56
EX-10.1
from 10-Q 11 pages Executive Employment Agreement for Brian Powl
12/34/56
EX-10.2
from 10-Q 22 pages Stock Option Grant Notice - International
12/34/56
EX-10.1
from 10-Q 3 pages Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10
from 10-Q 15 pages Re: Transition and Separation Agreement Dear Kirsten: Kura Oncology, Inc. (The “Company”) Has Accepted Your Notice of Resignation to Pursue Other Opportunities. This Letter Sets Forth the Terms of the Separation Agreement (The “Agreement”) That the Company Is Offering to You to Aid in Your Employment Transition. 1
12/34/56
EX-10
from 10-K 7 pages Kura Oncology, Inc. Rsu Award Grant Notice
12/34/56
EX-10
from 10-K 28 pages Kura Oncology, Inc. Amended and Restated 2014 Equity Incentive Plan Amended and Restated by the Board: March 6, 2015 Approved by the Stockholders: March 6, 2015
12/34/56
EX-10.1
from 8-K 31 pages Securities Purchase Agreement
12/34/56
EX-10.32
from 10-K 10 pages February 4, 2022 Marc Grasso, M.D. Re: Separation Agreement Dear Marc: This Letter Sets Forth the Terms of the Separation Agreement (The “Agreement”) That Kura Oncology, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1
12/34/56
EX-10.1
from 8-K 39 pages Kura Oncology, Inc. $150,000,000 Common Stock Sales Agreement
12/34/56
EX-10.31
from 10-K 11 pages Kura Oncology, Inc. Executive Employment Agreement for Teresa Bair
12/34/56
EX-10.30
from 10-K 13 pages Kura Oncology, Inc. Rsu Award Grant Notice - International
12/34/56
EX-10.2
from 10-Q 5 pages Amended & Restated Executive Employment Agreement Amendment No. 1
12/34/56
EX-10.1
from 10-Q 76 pages Genesis Morehouse at 5510 Lease Bp3-Sd5 5510 Morehouse Drive LLC, a Delaware Limited Liability Company as Landlord, and Kura Oncology, Inc., a Delaware Corporation as Tenant
12/34/56
EX-10.8
from 10-Q 2 pages Kura Oncology, Inc. Amendment to Executive Employment Agreement for Stephen Dale
12/34/56
EX-10.7
from 10-Q 14 pages Kura Oncology, Inc. Executive Employment Agreement for Stephen Dale, M.D
12/34/56